Building Assays, Battling COVID on the Frontline, and What’s Next in Dx – Vincent Funari
This week on Diagnosing Dx, I’m joined by Vincent Funari, a genomics leader whose career spans from the Human Genome Project to pioneering liquid biopsy assays and driving innovation at NeoGenomics during its major growth years.
We dive into how Vincent scaled R&D through M&A, led testing innovation during the COVID-19 crisis, and earned praise from the FDA for breakthrough assay development.
He also reflects on his path from bench scientist to CSO,and what scientists need to know about making that leap.
🔥 What You’ll Learn:
• Why liquid biopsy and minimal residual disease (MRD) testing are…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.